Carmell Corp financial data

Symbol
CTCX, CTCXW on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
2403 Sidney Street, Suite 300, Pittsburgh, Pennsylvania
State of incorporation
Delaware
Fiscal year end
December 31
Former names
ALPHA HEALTHCARE ACQUISITION CORP III (to 7/20/2023)
Latest financial report
Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 123 % +672%
Debt-to-equity -13.5 K % -81111%
Return On Equity 8.12 K % +27587%
Return On Assets -21.6 % -146%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 19.2 M shares
Common Stock, Shares, Outstanding 19.4 M shares
Entity Public Float 149 T USD 0%
Common Stock, Value, Issued 1.94 K USD
Weighted Average Number of Shares Outstanding, Basic 22.9 M shares +1941%
Weighted Average Number of Shares Outstanding, Diluted 22.9 M shares +1941%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 3.73 M USD
Research and Development Expense 429 K USD -42%
Selling and Marketing Expense 100 K USD
Operating Income (Loss) -6.05 M USD +3.18%
Nonoperating Income (Expense) -2.17 M USD -292%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -17.9 M USD -73.2%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -16.9 M USD -63.1%
Earnings Per Share, Basic -0.14 USD/shares +92.7%
Earnings Per Share, Diluted -0.14 USD/shares +92.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 892 K USD
Inventory, Net 9.81 M USD
Other Assets, Current 17.6 K USD
Assets, Current 5.19 M USD +3979%
Property, Plant and Equipment, Net 170 K USD
Operating Lease, Right-of-Use Asset 798 K USD
Goodwill 19.3 M USD
Assets 6.18 M USD -96.1%
Accounts Payable, Current 4.28 M USD
Accrued Liabilities, Current 2.82 M USD +298%
Liabilities, Current 6.91 M USD +163%
Deferred Income Tax Liabilities, Net 7.84 M USD
Operating Lease, Liability, Noncurrent 666 K USD
Liabilities 7.57 M USD +189%
Retained Earnings (Accumulated Deficit) -61.8 M USD -4623%
Stockholders' Equity Attributable to Parent -1.39 M USD +96.5%
Liabilities and Equity 6.18 M USD -96.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.08 M USD -126%
Net Cash Provided by (Used in) Financing Activities -196 K USD -152%
Net Cash Provided by (Used in) Investing Activities -749 K USD
Common Stock, Shares Authorized 250 M shares
Common Stock, Shares, Issued 19.4 M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 892 K USD +3181%
Interest Paid, Excluding Capitalized Interest, Operating Activities 11.6 K USD -68.8%
Deferred Tax Assets, Valuation Allowance 12.1 M USD +22.1%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 12.1 M USD +22.1%
Operating Lease, Liability 813 K USD
Payments to Acquire Property, Plant, and Equipment 30.5 K USD +325%
Lessee, Operating Lease, Liability, to be Paid 973 K USD
Property, Plant and Equipment, Gross 1.06 M USD
Operating Lease, Liability, Current 147 K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 205 K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 205 K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 160 K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 205 K USD
Deferred Tax Assets, Operating Loss Carryforwards 8.78 M USD +14.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1 M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 205 K USD
Operating Lease, Payments 34.8 K USD +10.9%
Additional Paid in Capital 60.4 M USD
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 402 K USD
Depreciation, Depletion and Amortization 23.5 K USD -2.37%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 211 K USD +17.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%